56 Biggest Movers From Yesterday

Loading...
Loading...

Gainers

  • Aptevo Therapeutics Inc. APVO shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
  • Pasithea Therapeutics Corp. KTTA shares surged 153.4% to close at $5.60 on Tuesday after the company announced its subsidiary Pasithea Clinics has been approved to provide esketamine nasal spray for the treatment of resistant depression in adults.
  • Qualigen Therapeutics, Inc. QLGN surged 104.8% to close at $2.56 after a Zack's Small Cap research note showed a $9 price target on the stock.
  • Vallon Pharmaceuticals, Inc. VLON jumped 81.6% to settle at $7.30. HC Wainwright & Co, on Monday, initiated coverage on Vallon Pharmaceuticals with a Buy rating and announced a price target of $12.
  • Petros Pharmaceuticals, Inc. PTPI gained 75.9% to settle at $2.34. The company filed proxy statement for annual meeting after the market close on Monday.
  • iSpecimen Inc. ISPC gained 48.5% to close at $13.19. iSpecimen shares jumped over 80% on Monday after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
  • MediciNova, Inc. MNOV surged 44% to settle at $4.42. Zacks Small-Cap Research set $27 valuation on MediciNova.
  • Clarus Therapeutics Holdings, Inc. CRXT gained 43% to close at $5.74 after the company was granted a U.S. Patent titled 'Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.'
  • Esperion Therapeutics, Inc. ESPR surged 40.7% to settle at $10.02
  • Sunlands Technology Group STG rose 23.2% to close at $4.51 after reporting unaudited Q3 results.
  • Gracell Biotechnologies Inc. GRCL rose 22.1% to close at $7.79. Gracell Biotech said members of its senior mgmt. team, including, Chair, CEO, CFO, Chief Medical Officer intend to use personal funds to buy up to $2 million in company’s ADSs in open market over next 3 months.
  • Dycom Industries, Inc. DY climbed 19.7% to close at $99.91 following upbeat Q3 results.
  • Enanta Pharmaceuticals, Inc. ENTA gained 15.1% to settle at $86.50 after the company reported Q4 earnings results.
  • BM Technologies, Inc. BMTX jumped 14.9% to close at $13.82. Chardan Capital initiated coverage on BM Technologies with a Buy rating and announced a price target of $21.
  • Unicycive Therapeutics, Inc. UNCY rose 14.7% to close at $2.88. Unicycive Therapeutics recently posted a Q3 loss of $0.37 per share.
  • Reliance Global Group, Inc. RELI gained 14.7% to settle at $2.42.
  • Armata Pharmaceuticals Inc. ARMP jumped 14.3% to settle at $5.53. The FDA recently cleared Armata Pharmaceuticals’ Investigational New Drug (IND) for Phase 1b/2a study of AP-SA02 in Staphylococcus aureus bacteremia.
  • QIWI plc QIWI rose 12.7% to settle at $8.70 after the company reported better-than-expected Q3 sales results.
  • Movado Group, Inc. MOV gained 11.7% to close at $44.58 following Q3 results.
  • Dollar Tree, Inc. DLTR surged 9.2% to settle at $144.71 after the company reported better-than-expected Q3 sales results.
  • Kosmos Energy Ltd. KOS gained 9.1% to close at $3.71.
  • Burlington Stores, Inc. BURL surged 8.6% to close at $285.55 after the company reported better-than-expected Q3 results.
  • XPeng Inc. XPEV jumped 8.3% to close at $51.30. XPeng reported third-quarter revenues that exceeded expectations but the loss per share trailed expectations. The company's gross margins expanded both sequentially and year-over-year.
  • XL Fleet Corp. XL gained 6.7% to close at $4.95 after the company announced it was awarded a pilot project with the Department of Defense to prototype fuel-saving technology for tactical vehicles.
  • Western Digital Corporation WDC gained 6.3% to close at $60.53. Mizuho analyst Vijay Rakesh upgraded Western Digital to Buy from Neutral with a price target of $75, up from $55, implying a 31.7% upside.
  • Soligenix, Inc. SNGX rose 5.8% to settle at $0.8790. Soligenix recently posted a Q3 loss of $0.09 per share.
  • Tonix Pharmaceuticals Holding Corp. TNXP shares rose 4.9% to close at $0.4882. The FDA has signed off Tonix Pharmaceuticals’ Investigational New Drug (IND) Application to initiate Phase 2 study of TNX-1900 for migraine.


Check out these big penny stock gainers and losers

Losers

  • Society Pass Incorporated SOPA dipped 71.3% to close at $11.18 on Tuesday. The company, earlier during the month, priced its IPO at $9 per share.
  • Longeveron Inc. LGVN shares dropped 38.9% to close at $17.22 on Tuesday. The company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
  • Enjoy Technology, Inc. ENJY fell 33.5% to close at $4.30. Enjoy Technology recently posted Q3 loss of $0.83 per share.
  • Greenland Technologies Holding Corporation GTEC fell 28.1% to close at $8.41. Greenland Technologies will present at the upcoming Sequire Cleantech & Electric Vehicle Investor Conference to be held virtually on December 6, 2021.
  • Genius Sports Limited GENI fell 25.3% to close at $10.19 after the company reported better-than-expected Q3 sales results and raised FY21 sales guidance above estimates.
  • Grom Social Enterprises, Inc. GROM fell 22.2% to settle at $2.25.
  • Entrada Therapeutics, Inc. TRDA dipped 20.6% to close at $24.13. Goldman Sachs initiated coverage on Entrada Therapeutics with a Neutral rating and announced a price target of $29.
  • Vinco Ventures, Inc. BBIG declined 20% to close at $3.13. Vinco Ventures reported a third-quarter FY21 sales decline of 11.5% year-on-year, to $2.23 million.
  • Local Bounti Corp. LOCL dipped 19.1% to settle at $8.01.
  • Aurora Innovation, Inc. AUR fell 18.7% to close at $12.15.
  • Sarcos Technology and Robotics Corporation STRC dropped 18% to settle at $6.58. Credit Suisse initiated coverage on Sarcos Technology with a Neutral rating and announced a price target of $9.
  • Benson Hill, Inc. BHIL dipped 17.6% to settle at $6.10. Goldman Sachs initiated coverage on Benson Hill with a Neutral rating and announced a price target of $9.
  • Science 37 Holdings, Inc. SNCE fell 17.1% to close at $9.43.
  • PainReform Ltd. PRFX fell 17% to close at $1.91. PainReform recently posted a net loss of $5.5 million during the nine months ended Sept. 30, 2021.
  • Femasys Inc. FEMY dipped 16.8% to settle at $4.06.
  • Design Therapeutics, Inc. DSGN fell 16.3% to close at $17.00.
  • Momentus Inc. MNTS dropped 15.5% to settle at $6.88.
  • Tyra Biosciences, Inc. TYRA declined 15.5% to settle at $19.34.
  • Zoom Video Communications, Inc. ZM fell 14.7% to close at $206.64. Zoom Video reported better-than-expected results for its third quarter on Monday. The company reported its customers that contribute more than $100,000 in the trailing 12 months totaled 2,507, up 94% year-over-year. B of A Securities downgraded Zoom from Buy to Neutral and lowered the price target from $385 to $270.
  • GameStop Corp. GME dropped 13.6% to settle at $213.90 amid overall weakness as a rise in yields weighs on stocks.
  • Abercrombie & Fitch Co. ANF fell 12.6% to close at $41.12 after the company reported Q3 earnings results.
  • Best Buy Co., Inc. BBY fell 12.3% to close at $121.01 after the company reported third-quarter FY22 Enterprise sales growth of 0.5% year-on-year, to $11.91 billion, beating the analyst consensus of $11.56 billion. Enterprise comparable sales increased 1.6% versus 23.0% growth last year.
  • The Lovesac Company LOVE fell 10.7% to close at $72.34. Andrew R Heyer, Insider at Lovesac, made a large insider sell on November 19, according to a new SEC filing.
  • Urban Outfitters, Inc. URBN fell 9.3% to close at $33.80. Urban Outfitters posted upbeat earnings and sales results for the third quarter. Its same-store sales climbed 14.6% year-over-year during the quarter.
  • Adamis Pharmaceuticals Corporation ADMP fell 8.4% to close at $0.8068. Adamis Pharmaceuticals said sales for the nine months ended Sept. 30, 2021 came in at $3.4 million.
  • Relay Therapeutics, Inc. RLAY fell 7.8% to close at $31.61.
  • Central Garden & Pet Company CENTA dropped 6.3% to close at $46.59 following Q4 results.
  • Hibbett, Inc. HIBB dropped 5.3% to close at $94.41. Hibbett is expected to issue its Q3 earnings release before the market opens on December 3, 2021.
  • DICK'S Sporting Goods, Inc. DKS declined 4.1% to close at $134.55 following Q3 results.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...